TrialJournal of gastroenterology2018

Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study.

Yoshiiku Kawakami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.